AISen Life and Xplorer BioForge Strategic Collaboration to Pioneer a New Era in Anti-Aging and Longevity Industry

Jun 16, 2025 14:30 CST Updated 14:30

Xbiome

AI Drug Developer for Gut Microbiota

Recently,Xbiome Co. Ltd. (hereinafter referred to as "Xbiome") and Guangxi Aisheng Life Technology Co., Ltd. (hereinafter referred to as "Aisheng Life") officially signed the "Cooperation Framework Agreement".Both parties use strategic synergy as the pen and technological innovation as the ink to jointly draw a new blueprint for the development of the anti-aging and longevity industry. The aim is to create a scientific anti-aging and longevity brand matrix with international competitiveness, build a full-chain cooperation ecosystem, and enhance China's discourse power and influence in the global anti-aging field.

Dr. Tan Yan, co-founder and CEO of Xbiome, Dr. Kuang Zhong, special researcher of the 50-member Forum for Health China, president of the Longevity Project Branch of the China Anti-Aging Promotion Association, and chairman of Guangxi Aisheng Life Technology Co., Ltd., as well as Dr. Luo Weifei, president, chief technology officer, and chief product officer of Guangxi Aisheng Life Technology Co., Ltd., and other core team members from both companies attended the signing ceremony.

XbiomeXbiome is one of the first and leading microbial pharmaceutical companies in China, possessing a cutting-edge AI microbiome research and industrial transformation platform. The company focuses on three key areas for its business layout: FMT (fecal microbiota transplantation), drug discovery, and probiotics. In recent years, Xbiome has successfully converted multiple scientific research achievements into products and services in the fields of probiotics and intestinal microbiota transplantation, achieving remarkable results in the transformation of biotechnology achievements.Inject strong momentum into cooperation with scientific research and technical strength.

Guangxi Aisheng Life Technology Co., Ltd.As a leading company in China's anti-aging and longevity field, after years of deep cultivation, it has established an integrated industrial ecosystem that combines industry, academia, research, and application. The company has assembled a professional team composed of top domestic scientific researchers and overseas returnees, achieving a series of breakthrough results in the research of anti-aging ingredients and product formula optimization. Its self-developed range of anti-aging products have gained excellent market reputation during past China-ASEAN Expo and other major health exhibitions, securing a strong position not only in the domestic market but also actively expanding into overseas markets, establishing itself as a benchmark for national anti-aging brands.

Currently, the global anti-aging and longevity market is developing rapidly. Consumers' demands for products are no longer limited to basic efficacy but focus more on the scientific nature of ingredients, technological innovation, and brand authority. However, the industry generally faces issues such as serious brand homogenization and a low conversion rate of scientific research achievements. Against this backdrop, Guangxi Aisheng Life Technology Co., Ltd. and Xbiome have set three core goals for their cooperation: integrating multi-party resources to build a science-based brand matrix covering fields such as skincare, health products, and medical services; establishing a full-chain cooperative ecosystem from basic research, product development, and large-scale production to market promotion; and enhancing China's scientific discourse power and market influence in the global anti-aging field through joint research efforts and international cooperation.

In the field of longevity and anti-aging product research, the two parties will jointly establish a collaborative research and development center, based in China while looking toward the global market. This center will rely on the cutting-edge high ground of global life science research, utilizing its deep scientific research foundation and top-tier research team to explore key topics such as the screening of novel anti-aging ingredients and the analysis of aging mechanisms. It aims to accelerate the development process of innovative anti-aging products and is committed to providing consumers with more scientific and effective anti-aging solutions.

In subsequent collaborations, both parties will share R&D resources and technology platforms, engage in customized product development, optimize the allocation of production resources, and ensure the stability and reliability of product quality. At the same time, both parties will establish professional operation teams for joint IP development. By hosting international anti-aging academic forums, launching science popularization documentaries, and other diversified methods, they will integrate their resources in scientific research, branding, and marketing to build a scientifically authoritative, professional, and widely influential anti-aging brand image. This collaboration aims to enhance the brand's reputation and popularity within the industry. Leveraging the joint brand as a link, both parties will deeply integrate resources to jointly shape a high-quality Chinese anti-aging and longevity brand image. Through online and offline integration, they will promote and sell products.

Dr. Tan Yan and Dr. Kuang Zhong Discuss Cooperation Content

"This collaboration represents a deep integration of 'strength + strength.'" Dr. Kuang Zhong, Chairman of Guangxi Aisheng Life Technology Co., Ltd., stated at the signing ceremony, "The combination of Aisheng Life's market advantages and Xbiome's technological strengths will undoubtedly lead to more competitive products and services, offering global consumers a brand-new anti-aging experience." Dr. Tan Yan, co-founder and CEO of Xbiome, also expressed confidence in the partnership: "We will take this cooperation as an opportunity to accelerate the transformation of scientific research achievements, jointly building an international reputation for China’s anti-aging brands, showcasing the power of China’s anti-aging technology to the world."

This strategic cooperation is not only an important milestone in the development history of both parties, but will also inject strong momentum into the high-quality development of China's anti-aging and longevity industry, helping the industry gain a place in global market competition and bringing new hope for health and longevity to hundreds of millions of consumers.

-End-

About Xbiome

Xbiome Co. Ltd., founded in 2017, owns a leading AI microbiome research and industrial transformation platform, strategically focusing on FMT, drug discovery, and probiotics. In drug discovery, the team has completed layouts in fields such as oncology, digestive system diseases, immune-related diseases, and urinary system diseases, with four pipelines entering clinical stages, two of which have reached phase II clinical trials. Regarding FMT, Xbiome has collaborated with nearly 20 well-known tertiary hospitals in China, including Peking University Cancer Hospital and Peking Union Medical College Hospital, on intestinal microbiome clinical research across various indications. Additionally, they have developed the AI-FMT personalized precision treatment project targeting the broader health market to benefit patients with chronic diseases and sub-health populations. In the probiotics field, Xbiome has successfully completed commercial collaborations and transformations with several top domestic and international health companies while continuing to advance the development of proprietary strains.